Dr. Doris Leung, MD
Claim this profileKennedy Krieger Institute
Area of expertise
Duchenne Muscular Dystrophy
Doris Leung, MD has run 4 trials for Duchenne Muscular Dystrophy. Some of their research focus areas include:
Myelodysplastic Syndrome
Doris Leung, MD has run 4 trials for Myelodysplastic Syndrome. Some of their research focus areas include:
Affiliated Hospitals
Kennedy Krieger Institute
Kennedy Krieger Institute Center For Genetic Muscle Disorders
Clinical Trials Doris Leung, MD is currently running
Motor Outcomes Evaluation
for Facioscapulohumeral Muscular Dystrophy
The primary goal of this proposal is to collect motor and functional outcomes specific to FSHD over time. By collecting measures specific to FSHD, this will help ensure the best level of clinical care is being provided. Also, the hope is to speed up drug development by gaining a better understanding of how having FSHD impacts motor function and other health outcomes (i.e. breathing, wheelchair use, etc.) and how big a change in motor function would be clinically meaningful to those with FSHD. Motor Outcomes to Validate Evaluations in FSHD (MOVE FSHD) will have approximately 450 FSHD participants followed for a minimum of 3 years. A subset of MOVE FSHD participants, approximately 200, will participate in the MOVE+ sub-study which includes whole body MRI and reachable workspace, as well as optional muscle biopsy and wearable device (US participants only).
Recruiting
1 award
N/A
1 criteria
LION-101
for Limb-Girdle Muscular Dystrophy
This trial is testing the safety and tolerability of an IV dose of AB-1003 in adults with a specific type of muscular dystrophy (LGMD2I/R9). The goal is to see if the treatment can help improve muscle function or slow down muscle damage.
Recruiting
0 awards
Phase 1 & 2
More about Doris Leung, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Doris Leung, MD has experience with
- Placebo
- Corticosteroids
- Pamrevlumab
- BBP-418 (Ribitol)
- Pitolisant Oral Tablet
- Placebo Oral Tablet
Breakdown of trials Doris Leung, MD has run
Duchenne Muscular Dystrophy
Myelodysplastic Syndrome
Muscular Dystrophy
Limb-Girdle Muscular Dystrophy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Doris Leung, MD specialize in?
Doris Leung, MD focuses on Duchenne Muscular Dystrophy and Myelodysplastic Syndrome. In particular, much of their work with Duchenne Muscular Dystrophy has involved DMD patients, or patients who are Duchenne mutation positive.
Is Doris Leung, MD currently recruiting for clinical trials?
Yes, Doris Leung, MD is currently recruiting for 2 clinical trials in Baltimore Maryland. If you're interested in participating, you should apply.
Are there any treatments that Doris Leung, MD has studied deeply?
Yes, Doris Leung, MD has studied treatments such as Placebo, Corticosteroids, Pamrevlumab.
What is the best way to schedule an appointment with Doris Leung, MD?
Apply for one of the trials that Doris Leung, MD is conducting.
What is the office address of Doris Leung, MD?
The office of Doris Leung, MD is located at: Kennedy Krieger Institute, Baltimore, Maryland 21205 United States. This is the address for their practice at the Kennedy Krieger Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.